Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lundbeck

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lundbeck's 2013 CNS (central nervous system) sales performance.

Newron back on track for Xadago approval in US

Newron back on track for Xadago approval in US The monoamine oxidase type B inhibitor is used as an add-on to levodopa therapy - the mainstay of Parkinson's disease treatment - and competes with Lundbeck and Teva's Azilect (rasagiline),

Surging sales of Lundbeck's CNS drugs assist recovery

Surging sales of Lundbeck's CNS drugs assist recovery Two newer antidepressants help boost sales after Cipralex patent ends.  . Surging sales of four new central nervous system drugs helped Denmark's Lundbeck post a 5% sales increase in the second ... Lundbeck has now raised its revenue and earnings

SMC gives green light for BMS’ Opdivo

SMC gives green light for BMS’ Opdivo 2014. Additionally, the SMC gave three further approvals to Lundbeck's antidepressant Brintellix (vortioxetine), Novartis' Cosentyx (secukinumab) for ankylosing spondylitis, and UCB's Briviact (brivaracetam) for partial-onset seizures in epilepsy

Caring for Carers

by Hill Knowlton Strategies for Otsuka Lundbeck. H K saw an opportunity for Lundbeck to address the unmet needs of family carers, looking after their loved ones who suffer from diseases ... Caring for Carers - by Hill Knowlton Strategies for Otsuka

Driet: The Drinking Diet

by Reynolds-MacKenzie for Lundbeck/Accretio. ‘Wine o’ clock’, book clubs, lunches - a group of ladies sharing a bottle of wine is a common scene in today’s Britain. ... Accretio, in partnership with Lundbeck, challenged us to create a campaign

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics